November 24, 2020
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical development and in need of drug safety, Arcturus Therapeutics has expanded its retainer with The Chase Group to include an executive search for a Head of Drug Safety. Responsible for providing leadership, oversight, and strategic vision for drug safety, the successful candidate will build out the department and construct the drug safety plan for Arcturus’ rapidly moving vaccine program. The Chase Group has a vast network of drug safety leaders and is poised to identify the high caliber talent Arcturus needs to catalyze the next generation of mRNA medicines. To learn more about The Chase Group’s executive search services, email ken@chasegroup.com.
